TriangleHEALTH PROFESSIONAL · SOURCE READING
Tumor Mutational Burden–High (TMB-H) (≥16 Mutations/Megabase [mut/Mb]) Solid Tumors
Source: Agnostic Cancer Therapies (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Potential Emerging Agnostic Targets Not Yet Approved by the U.S. Food and Drug Administration
Continue within this section
Preserved source evidence · Independent clinical review pending · Not medical advice